© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
784192 |
As an accredited 3-Bromo-4-Hydroxy-5-Nitropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-4-Hydroxy-5-Nitropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
If you often look for organic intermediates that deliver high reliability and flexibility, 3-Bromo-4-Hydroxy-5-Nitropyridine (often colloquially dubbed as "the BHN pyridine variant" by researchers in my old lab) stands out in a crowded field. Its chemical formula (C5H3BrN2O3) doesn’t raise eyebrows at first glance, but a closer look uncovers quite a bit about its value, especially in the world of fine chemicals, pharmaceutical intermediates, and heterocyclic synthesis.
Over the years, organic chemists have learned that certain building blocks open more doors than others. I remember, back during grad school, hearing colleagues talk about how placing both a nitro group and a bromine atom on a pyridine ring wasn't some arbitrary design choice. Adding a hydroxy group at the four-position does more than just tweak solubility—a combination of these modifications sets the stage for more specific and nuanced reactions, especially during catalytic or nucleophilic substitutions.
3-Bromo-4-Hydroxy-5-Nitropyridine sits at the intersection of versatility and selectivity. Its bromine atom offers a reactive handle for cross-coupling, more so than its chloro analogs, which often stall out or demand harsher reaction conditions. Anyone who has tried Suzuki or Buchwald-Hartwig couplings with bromo aromatics knows the difference—reactions tend to proceed more smoothly, with fewer surprises during workup and purification.
The molecular skeleton of this compound matters, not simply for academic reasons but for its direct effect on lab work. The electron-withdrawing nitro group at the five-position draws down the reactivity of the ring, subtly steering substitution patterns. In the world of small molecule design, that extra bit of electronic control can spell the difference between a clean transformation and a chromatographic headache. The hydroxy group at position four throws in another lever for tuning hydrogen-bonding interactions, opening up new relationships with solvents and reagents.
Many chemists fall back on standard pyridine derivatives when setting up heterocycle frameworks. This compound, though, offers something of a trump card. I once watched a team wrangle a multi-step synthesis, struggling to coax a key intermediate along. Switching from plain old 3-bromopyridine to this particular variant cleaned up their yields, made purification less of a slog, and neatly knocked out a persistent side reaction. There’s no overstating the relief in the lab when a single swap streamlines weeks of work.
Chemical catalogs overflow with pyridines sporting different substituents. What sets 3-Bromo-4-Hydroxy-5-Nitropyridine apart? It's not just an academic question—it’s a practical one in terms of reactivity and cost. Compared to its closest neighbors, like 3-bromo-5-nitropyridine or 4-hydroxy-3-bromopyridine, the arrangement of functional groups on this molecule leads to unique behavior.
For one, the ortho-nitro and para-hydroxy arrangement amplifies polarization, boosting certain nucleophilic aromatic substitutions that would sputter along with less activated rings. In pharmaceutical R&D settings, this means more ways to link up tailored side chains or build complexity into lead compounds. I’ve heard colleagues in medicinal chemistry talk about this variant as a kind of shortcut—a way to dodge laborious protection-deprotection steps that slow down analog synthesis. Paired with robust supply channels and a track record of batch consistency, you begin to see why this pyridine draws repeat orders in both academic circles and industry pilot plants.
While academic literature covers the basics, practical applications go further. Take kinase inhibitor development, where the unique electronic footprint of the compound creates new binding motifs. This sometimes tips the scales during lead optimization, letting teams try approaches that standard pyridines can’t access. It also pops up in the dye and pigment industries, where the interplay between bromine and nitro groups brings out new hues or improves colorfastness in specialty textiles.
The hydroxy group’s position is not just a cosmetic choice. In my own experience scaling up a batch in a kilo lab, the hydrogen bonding offered by the hydroxy group guided solubility in key solvents, which allowed us to dodge problematic precipitation mid-way through a crucial reaction sequence. The team saved time and avoided solvent swaps, a detail that looks minor on a whiteboard but means everything during a tight production schedule.
One underrated aspect involves metal-catalyzed couplings. The presence of bromine turns this molecule into an inviting candidate for palladium-catalyzed reactions, a backbone of modern medicinal chemistry. Palladium-based couplings with boronic acids or amines proceed at lower temperatures than with chloro analogues, and cleaner conversions reduce the need for complicated work-ups. This isn’t just about convenience. Cleaner reactions translate into lower impurities, better yields, and sometimes the difference between a viable drug candidate and one doomed by a problematic impurity profile.
On paper, you might not see much between it and another halogenated pyridine—until you run both side by side on the bench. The hydroxy group at the four-position interacts differently during derivatization, compared to methyl or amino variants. These subtleties echo down the line, affecting everything from crystallization habits to long-term stability in storage.
You won't hear folks reminisce fondly about a batch with inconsistent purity—those stories tend to come with groans. For 3-Bromo-4-Hydroxy-5-Nitropyridine, reliable access to high-grade material makes or breaks project timelines. Analytical purity (often not less than 98 percent) and a controlled moisture profile reduce headaches with batch-to-batch variation. In multi-step syntheses, stacking variables leads to surprises; quality materials minimize that risk. Environmental health and safety protocols in reputable facilities add confidence for users concerned about trace contaminants or batch irregularities—an area manufacturers have improved over the past decade after industry-wide wake-up calls about lab safety and product recalls.
This variant’s “model,” so to speak, isn’t about marketing gloss. Chemists care about reactivity trends, impurity profiles, and how a compound behaves—predictably or otherwise—during downstream transformations. Based on firsthand project logs and published papers, this molecule consistently shows solid performance in both aqueous and organic media. Solubility advantage kicks in at the hydroxy end, while the nitro group imparts desirable reactivity modulation.
Trying to generalize about its performance misses the real story. In one case, a process chemistry group swapped inferior analogs for this compound, pushing a stalled synthesis to completion and ending a lengthy troubleshooting cycle. Subtle changes in molecule architecture—like shifting the hydroxy placement—reshaped the way their intermediates behaved during crystallization, letting them finally meet tight specifications for a clinical candidate.
Like any high-functioning specialty chemical, 3-Bromo-4-Hydroxy-5-Nitropyridine carries its own challenges. Cost sometimes sits higher than simpler alternatives, though the time and efficiency gains often justify the outlay. Certain transformations still call for protective strategies on the hydroxy group, especially if an aggressive nucleophile’s in the mix. Anyone who’s run into rogue over-reactions knows the headache.
Process scalability appeared on my team’s radar once, after observing slight yield drift between pilot and commercial scales. Tweaks to solvent ratios and a more robust drying protocol narrowed this gap. Sharing notes with others in the field, it’s clear these pragmatic fixes show up again and again: spend time on process optimization up front, and avoid downstream complications, whether it’s in small-scale medicinal chemistry campaigns or full-bore manufacturing.
Sensible risk management is part of the game. The bromine and nitro substituents raise flags for skin and respiratory irritation—no surprise if you’ve handled halogenated organics before. Gloves, goggles, and careful transfer practices eliminate most risks. I’ve always reminded new team members to respect these compounds in the hood, not just because of the safety data sheet, but from near-misses over the years. Shortcuts tempt fate more than they save time.
Waste disposal, especially with halogenated organics, deserves attention. Over the past decade, labs increasingly move toward greener protocols for quenching and solvent recycling, both for compliance and to align with sustainability initiatives. These shifts mark progress, though not every facility can yet make everything closed-loop. Still, with 3-Bromo-4-Hydroxy-5-Nitropyridine, mainstream safety practices more than handle its risks; disciplined use and proper handling make incidents rare.
As anyone sourcing intermediates knows, delays can wreck best-laid plans. Over the past five years, reliable suppliers dialed in their logistics for 3-Bromo-4-Hydroxy-5-Nitropyridine, responding to steady demand from both pharma and fine chemicals users. API manufacturers and CROs count on recurring orders of this compound for both process R&D and routine campaign work, helped by well-documented quality controls and transparent supply chains.
Documentation, provenance, and batch analytics stand as important as the compound itself. Regulatory needs in pharma drive this rigor, but even exploratory academic projects gain from clearer source transparency. I remember the frustration in earlier years, chasing down spectra for poorly documented batches. Now, reputable suppliers provide comprehensive analytical data—NMR, HPLC, residual solvents—that lets users hit the ground running instead of chasing ambiguity.
While demand for 3-Bromo-4-Hydroxy-5-Nitropyridine continues to grow, its roles evolve with new synthetic methods. Researchers experimenting with photoredox catalysis or metal-free cross-couplings find this compound flexible for up-and-coming approaches, not just tried-and-true protocols. Its robust, predictable reactivity profile reassures teams pushing boundaries on new synthetic routes, especially where other pyridine derivatives fall short.
Solid-state chemistry teams now explore its behavior in co-crystal formation, aiming to tweak solubility and deliver new pharmaceutical polymorphs. The unique arrangement of substituents on the pyridine ring means this compound can form strong and well-defined hydrogen-bonding networks, leading to more predictable crystallization outcomes—a key consideration for anyone dealing with scale-up or regulatory filings. Formulation scientists find value in the hydroxy group, which often boosts solubility or offers targeted sites for further chemical elaboration.
With any specialty chemical, clear lines of communication spread lessons and minimize wasted effort. Chemists on professional forums and at conferences regularly swap tips about handling, storage, and best synthetic detours. I’ve benefited from this communal wisdom, realizing that seemingly simple tricks—like using slightly damp solvents with this compound to moderate reactivity in specific SNAr reactions—save days of trouble. Ongoing, open discussion among those who work with 3-Bromo-4-Hydroxy-5-Nitropyridine keeps the whole field moving forward, as both academic and industrial labs contribute to the growing knowledge base.
Many lessons with this compound come down to smart preparation. Dedicated storage, consistent desiccation, and periodic re-testing keep even long-standing stocks reliable. Reaction optimization, based on up-to-date literature and community advice, minimizes re-work. Process engineers continue to tweak both reactions and purifications to stretch every last point of yield and purity, enabled by a strong understanding of 3-Bromo-4-Hydroxy-5-Nitropyridine’s properties. Their efforts ripple through project timelines, ultimately trimming cost and accelerating discovery or manufacturing milestones.
On the environmental front, emerging protocols offer greener alternatives to classic procedures. Solvent reduction, improved recycle streams, and careful control of waste align well with the material’s handling requirements. These changes don’t solve every challenge overnight, but they show the way toward more sustainable use of specialty intermediates across the field.
Pharma and fine chemical sectors see rising compliance and documentation needs for all core building blocks, including this molecule. Recent shifts in both European and Asian regulatory environments put extra focus on traceability, contaminant profiles, and worker safety. Leading suppliers of 3-Bromo-4-Hydroxy-5-Nitropyridine adjusted by tightening quality oversight, expanding traceability, and publishing third-party audits. These upgrades sound dry, yet save end-users hassle and support robust filings with health authorities—an element that repeatedly makes or breaks time-to-market.
Managing the day-to-day with this compound translates to good lab habits, careful inventory control, and—crucially—regular communication with suppliers. Chemistry departments and process teams track batches and monitor performance in synthesis, keeping notes on subtle differences across lots. When challenges surface, coordinated dialogue with knowledgeable vendors and cross-functional teams resolves issues faster and more accurately than siloed work. Openly shared chromatograms, impurity profiles, and process steps make course corrections quicker. In my own projects, pulling in a supplier’s technical team to troubleshoot stuck reactions or confirm purity shortcuts delays. This cooperative approach, repeated lab after lab, turns potential frustration into satisfactory progress for both research and plant operations.
3-Bromo-4-Hydroxy-5-Nitropyridine reflects the way small choices in molecule design echo through every stage of discovery and production. More than just another aromatic intermediate, this compound enables advances in pharmaceuticals, materials science, and specialty chemicals. Its unique combination of electronic features, functional group placements, and practical track record give it staying power and growing relevance. By combining informed sourcing, sharp lab technique, and a willingness to engage with evolving knowledge, chemists and manufacturers keep driving better outcomes, supported by a compound that proves itself both in routine work and in challenging new directions.
